Skip to main content
. 2020 Nov 23;10:20412. doi: 10.1038/s41598-020-77532-x

Figure 2.

Figure 2

Kaplan–Meier survival analysis and SMARCA4 mRNA expression according to the 30th percentile as cut off-value in the whole cohort and in the subgroup of “high-grade OC” patients. (a) Progression free survival in 238 OC patients, (b) overall survival in 238 OC patients, (c) progression free survival in 186 “high-grade OC” patients, (d) overall survival in 186 “high-grade OC” patients.